Dr. Saveen Semage re-appointed as CEO of NMRA

The Ministry of Health announced the re-appointment of Dr. Saveen Semage as the new Chief Executive Officer (CEO) of the National Medicines Regulatory Authority (NMRA) today (January 09).
Dr. Saveen Semage previously served as the CEO of the NMRA from November 2021 until May 2022, before he resigned from the position.
In May 2022, Dr. Saveen Semage announced his resignation as the CEO of NMRA on social media, blaming the move by Ravi Kumudesh, President of the College of Medical Laboratory Science, over allegations leveled at NMRA over the drug shortage at that time.
The new appointment was made by Health Minister Dr. Ramesh Pathirana, following a selection process from among applications submitted for the vacant position.
Latest Headlines in Sri Lanka
- Sri Lankan President orders swift livelihood restoration for disaster-hit communities December 13, 2025
- Sri Lanka receives over USD 7 Billion in remittances in 2025 December 13, 2025
- Sri Lanka Parliament summoned to meet on December 18 December 13, 2025
- Sri Lanka and Italy renew agreement on mutual recognition of driving licenses December 13, 2025
- Asoka Ranwala granted bail December 12, 2025

